Overview
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous detachment of the neurosensory retina due to fluid leakage from the choroid, often leading to visual impairment 16.Diagnosis
Key Diagnostic Criteria: Presence of subretinal fluid (SRF) and serous retinal detachment 2.
Recommended Tests:
- Color fundus photography (CFP)
- Fundus fluorescein angiography (FFA) to assess retinal vascular leakage
- Indocyanine green angiography (ICGA) for choroidal lesion assessment
- Optical coherence tomography (OCT) to measure central foveal thickness (CFT) and SRF 27.
Differential Diagnosis: Important to rule out other macular disorders and conditions mimicking CSCR, such as age-related macular degeneration and certain inflammatory processes 9.Management
First-Line Treatments:
- Photodynamic therapy (PDT): Half-dose verteporfin PDT is highly effective for acute CSCR, significantly reducing SRF with 95% of treated patients having no SRF at 12 months 2.
Adjunctive Treatments:
- Intravitreal therapies: Limited evidence; specific drugs and dosing not detailed in provided abstracts 2.
- Systemic therapies: Use varies; no specific recommendations provided in abstracts 2.
Lifestyle Modifications: Discontinuation of suspected causative agents like excessive estrogen modulators (e.g., diindolylmethane) 6.Special Populations
Pregnancy: No specific guidelines provided in the abstracts 6.
Pediatrics: Not addressed in the provided abstracts 6.
Elderly: No specific considerations noted in the abstracts 6.
Comorbidities: Hypercortisolism and genetic predispositions (e.g., PTPRB variants) may influence CSCR development 36.Key Recommendations
Use half-dose verteporfin photodynamic therapy (PDT) for acute CSCR to significantly reduce subretinal fluid and improve visual outcomes (Evidence: Strong 2).
Employ multimodal imaging including OCT, FFA, and ICGA for accurate diagnosis and monitoring of CSCR (Evidence: Moderate 27).
Identify and discontinue potential causative agents such as excessive estrogen modulators when possible (Evidence: Expert opinion 6).
Consider genetic factors like PTPRB variants in patients with recurrent or atypical presentations (Evidence: Moderate 3).
Differentiate CSCR from other macular diseases using noninvasive diagnostic techniques to avoid unnecessary extensive evaluations (Evidence: Expert opinion 8).References
1 Pichi F, Miserocchi E, Grewal DS, Sharma S, Brézin AP, Bodaghi B et al.. Evidence and Consensus-based Imaging Guidelines in Birdshot Chorioretinopathy: Multimodal Imaging in Uveitis (MUV) Taskforce Report 8. American journal of ophthalmology 2025. link
2 Kim LA, Maguire MG, Weng CY, Smith JR, Jain N, Flaxel CJ et al.. Therapies for Central Serous Chorioretinopathy: A Report by the American Academy of Ophthalmology. Ophthalmology 2025. link
3 Rämö JT, Gorman BR, Weng LC, Jurgens SJ, Singhanetr P, Tieger MG et al.. Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma. Nature communications 2025. link
4 Zhang C, Ren X, Huang J, Huang L, Zhang X. Central serous chorioretinopathy secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS). Expert opinion on drug safety 2025. link
5 Mori Y, Miyake M, Hosoda Y, Miki A, Takahashi A, Muraoka Y et al.. Genome-wide Survival Analysis for Macular Neovascularization Development in Central Serous Chorioretinopathy Revealed Shared Genetic Susceptibility with Polypoidal Choroidal Vasculopathy. Ophthalmology 2022. link
6 Bussel II, Lally DR, Waheed NK. Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane. Ophthalmic surgery, lasers & imaging retina 2014. link
7 Stewart JM. Half dose verteporfin PDT for central serous chorioretinopathy. The British journal of ophthalmology 2006. link
8 Kraushar MF, Miller EM. Central serous choroidopathy misdiagnosed as a manifestation of multiple sclerosis. Annals of ophthalmology 1982. link
9 Woodruff ME. Diseases of the uvea - 1975 review. American journal of optometry and physiological optics 1977. link